Resmiterom Efficacy & Safety in Patients With MASH

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT06161571 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

NCT05500222 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)

NCT04697810 ·Status: RECRUITING ·Phase: PHASE2

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07288138 ·Status: RECRUITING ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)

NCT00740610 ·Status: COMPLETED ·Phase: PHASE2

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

NCT06920043 ·Status: RECRUITING ·Phase: PHASE2

A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

NCT03900429 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NCT06528314 ·Status: RECRUITING ·Phase: PHASE3

The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis

NCT02231333 ·Status: COMPLETED ·Phase: NA

A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database

NCT06741111 ·Status: COMPLETED

Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis

NCT06302049 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

NCT04951219 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH

NCT05118360 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

NCT04267393 ·Status: TERMINATED ·Phase: PHASE2

A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

NCT04767529 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH

NCT05462353 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients

NCT04197479 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease

NCT02927314 ·Status: COMPLETED ·Phase: PHASE2

Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis

NCT05357352 ·Status: COMPLETED

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

NCT06318169 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry

NCT07335198 ·Status: RECRUITING ·Phase: PHASE1

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

NCT05327127 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis

NCT01591200 ·Status: COMPLETED ·Phase: PHASE2

A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

NCT02413372 ·Status: COMPLETED ·Phase: PHASE2

Effect of DMR in the Treatment of NASH

NCT03536650 ·Status: COMPLETED ·Phase: NA